Stoke Therapeutics STOK
NASDAQ STOK
$26.01 +0.01 (+0.04%)
At close: Oct 1, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Shares Outstanding (Entity) (2018 - 2026)

Updated

Stoke Therapeutics (STOK) posted Shares Outstanding (Entity) of 62.4 million for Q2 2026, up 14.0% from 54.72 million a year earlier and up 0.3% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends

For FY2025, Stoke Therapeutics' Shares Outstanding (Entity) came in at 58.92 million, up 9.0% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for six consecutive years, with a five-year compound annual growth rate of 10.0% (FY2020 to FY2025).
  • In prior years, Stoke Therapeutics' Shares Outstanding (Entity) was 54.03 million in FY2024 (+17.7%), 45.92 million in FY2023 (+16.4%), 39.44 million in FY2022 (+6.9%) and 36.9 million in FY2021 (+0.9%).
  • The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2018.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 25 quarters, with growth averaging 12.6% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 0.9% in Q4 2021 to 19.5% in Q3 2024.
  • According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 62.24 million (Q1 2026), 58.92 million (Q4 2025) and 55.12 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Stoke Therapeutics 1.62 Bn 453.12 Mn - 62.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62.40 Mn
Mar 31, 2026 62.24 Mn
Dec 31, 2025 58.92 Mn
Sep 30, 2025 55.12 Mn
Jun 30, 2025 54.72 Mn
Mar 31, 2025 54.60 Mn
Dec 31, 2024 54.03 Mn
Sep 30, 2024 52.94 Mn
Jun 30, 2024 52.31 Mn
Mar 31, 2024 46.50 Mn
Dec 31, 2023 45.92 Mn
Sep 30, 2023 44.29 Mn
Jun 30, 2023 44.20 Mn
Mar 31, 2023 44.18 Mn
Dec 31, 2022 39.44 Mn
Sep 30, 2022 39.43 Mn
Jun 30, 2022 39.38 Mn
Mar 31, 2022 39.04 Mn
Dec 31, 2021 36.90 Mn
Sep 30, 2021 36.78 Mn
API Access

Stoke Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=STOK&period=max&api_key=YOUR_API_KEY